2025 annual financial data

Enliven Therapeutics 2025 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -119.66M USD and net income was -103.69M USD.
Operating cash flow was -70.3M USD.

Get free Enliven Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-119.66M USD
Net income
-103.69M USD
Operating cash flow
-70.3M USD